Clinical Trial Update: NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update for NGGT006 gene therapy targeting Homozygous Familial Hypercholesterolemia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• NGGT006

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Homozygous Familial Hypercholesterolemia | EARLY_Phase 1 | Status: RECRUITING